


April 2023 Top Biopharma Deal: DualityBio development and commercialization deal with BioNTech for DB-1303 and DB-1311 for cancer

March 2023 Top Biopharma Deal: OncoC4 – BioNTech for ONC-392 for Solid Tumors and NSCLC

February 2023 Top Biopharma Deal: Axsome – Pharmanovia for EDS Drug Sunosi

January 2023 Top Biopharma Deal: Hutchmed – Takeda for cancer drug fruquintinib
